GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (FRA:8RK) » Definitions » Net Income (Continuing Operations)

Labiana Health (FRA:8RK) Net Income (Continuing Operations) : €-1.19 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Labiana Health's Net Income (Continuing Operations) for the six months ended in Jun. 2024 was €1.18 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.19 Mil.

Labiana Health Net Income (Continuing Operations) Historical Data

The historical data trend for Labiana Health's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Net Income (Continuing Operations) Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
1.07 -2.11 -9.11 -4.49

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Income (Continuing Operations) Get a 7-Day Free Trial -1.62 -7.49 -2.12 -2.37 1.18

Labiana Health Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labiana Health  (FRA:8RK) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Labiana Health Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Labiana Health's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (FRA:8RK) » Definitions » Net Income (Continuing Operations)
Comparable Companies
BOM:521141 BOM:531744 BOM:514400 BOM:539546 BOM:514280 BOM:531223 BOM:532140 BOM:514318 BOM:521131 NSE:VCL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
LAB:Spain
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Website
https://www.labiana.com
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.

Labiana Health Headlines

No Headlines